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Axon properties, including action potential initiation and modulation,
depend on both AIS integrity and the regulation of ion channel
expression in the AIS. Alteration of the axon initial segment (AIS)
has been implicated in neurodegenerative, psychiatric, and brain
trauma diseases, thus identiﬁcation of the physiological mechanisms
that regulate the AIS is required to understand and circumvent AIS
alterations in pathological conditions. Here, we show that the puri-
nergic P2X7 receptor and its agonist, adenosine triphosphate (ATP),
modulate both structural proteins and ion channel density at the AIS
in cultured neurons and brain slices. In cultured hippocampal
neurons, an increment of extracellular ATP concentration or P2X7-
green ﬂuorescent protein (GFP) expression reduced the density of
ankyrin G and voltage-gated sodium channels at the AIS. This effect
is mediated by P2X7-regulated calcium inﬂux and calpain activation,
and impaired by P2X7 inhibition with Brilliant Blue G (BBG), or P2X7
suppression. Electrophysiological studies in brain slices showed that
P2X7-GFP transfection decreased both sodium current amplitude
and intrinsic neuronal excitability, while P2X7 inhibition had the
opposite effect. Finally, inhibition of P2X7 with BBG prevented AIS
disruption after ischemia/reperfusion in rats. In conclusion, our study
demonstrates an involvement of P2X7 receptors in the regulation of
AIS mediated neuronal excitability in physiological and pathological
conditions.
Keywords: ankyrin G, axon initial segment, BBG, brain ischemia, P2X7
receptor, sodium channels
Introduction
The axon initial segment (AIS) is not only the locus of action
potential initiation (Kole et al. 2008) but it also plays an essen-
tial role in maintaining axon integrity and identity (Hedstrom
et al. 2008). The property of spike initiation is conferred by the
high concentration of voltage-gated ion channels in the AIS
(Bender and Trussell 2012) maintained by cytoskeletal pro-
teins, such as ankyrin G or PSD-93 (Garrido et al. 2003; Pan
et al. 2006; Ogawa et al. 2008). The cellular and molecular
machinery that ﬁnely modulates functional expression of ion
channels at the AIS remains mostly unknown. Recent studies
have shown that kinases in the AIS (i.e., Casein kinase 2,
GSK-3, and cdk5) can modulate the density of AIS proteins
(Brechet et al. 2008; Sanchez-Ponce et al. 2011; Vacher et al.
2011; Tapia et al. 2013). Moreover, neuronal excitability is also
controlled in certain neuronal types through modiﬁcations of
the position and length of the AIS (Grubb and Burrone 2010;
Kuba et al. 2010). This AIS plasticity is controlled at least by
the inﬂux of calcium through T- and/or L-type voltage-gated
calcium channels or metabotropic glutamate receptors and
higher physiological [Ca2+]i, that modulate calcineurin activity
(Evans et al. 2013). Besides physiological regulation of the
AIS, AIS alterations have been reported in neurological dis-
orders and nervous system injury (Bufﬁngton and Rasband
2011). In this context, some neurological disorders, such as
Angelman syndrome or schizophrenia; or brain trauma are
related to structural alterations of the AIS or changes in the
expression of structural proteins and ion channels in the AIS
(Cruz et al. 2009; Kaphzan et al. 2011; Baalman et al. 2013;
Hinman et al. 2013). Moreover, AIS is disrupted after brain
ischemia by a calcium/calpain-dependent mechanism, inde-
pendent of N-methyl-D-aspartate (NMDA) receptor activation
(Schafer et al. 2009). In this sense, P2X purinergic receptors
are good candidates to control calcium inﬂux in physiological
and pathological conditions.
Seven P2X receptors have been cloned (P2X1-7). They are
all expressed in neurons and glial cells during brain develop-
ment and in adult brain. These receptors are activated by extra-
cellular adenosine 5′-triphosphate (ATP) and allow calcium
inﬂux to the same extent as NMDA receptors (Abbracchio et al.
2009). Among the 7 P2X purinergic receptors, P2X7 is the one
that needs higher ATP concentrations (>100 μM) for its acti-
vation (North and Surprenant 2000). In addition, it has been
proposed that P2X7 receptor triggers quantal release of ATP
(Gutierrez-Martin et al. 2011). P2X7 receptor stimulation has
been implicated in several nervous system diseases, such as
brain ischemia, epileptic seizures, multiple sclerosis, spinal
cord injury, Alzheimer’’s disease, or Huntington’s disease
(Vianna et al. 2002; Parvathenani et al. 2003; Wang et al. 2004;
Matute et al. 2007; Diaz-Hernandez et al. 2009; Kim et al. 2009;
Arbeloa et al. 2012). Furthermore, recent studies have shown
that suppression or inhibition of P2X7 receptor promotes
axonal growth, suggesting a role of their antagonists in axonal
regeneration and axonal physiology (Diaz-Hernandez et al.
2008; del Puerto et al. 2012).
Our study demonstrates that an increase in the extracellular
ATP concentration reduces the density of βIV-spectrin, ankyrin
G, and voltage-gated sodium channels at the AIS, via a process
that depends on P2X7 activity, calcium, and calpain. In this
sense, we show that AIS disruption observed after brain
ischemia is prevented by a P2X7 receptor antagonist. Finally,
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electrophysiological studies in brain slices show P2X7 involve-
ment in the modulation of sodium currents, action potential
generation and neuronal excitability. Thus, our study suggests
a new role for purines and ATP-gated P2X7 purinergic recep-
tors in the regulation of the AIS.
Materials and Methods
Reagents and Plasmids
ATP (A5394), Brilliant Blue G (BBG, B0770) and ethyleneglycol-bis
(2-aminoethylether)-N,N,N′,N′-tetra acetic acid (EGTA) (E3889) were
obtained from Sigma-Aldrich, Calpeptin was from Calbiochem
(03340051) and MDL-28170 from Tocris (1146). GFP plasmid was
obtained from Clontech, P2X7-GFP, P2X7 interference RNA and
scrambled RNA plasmids used in this study have been used and
described in previous publications (Diaz-Hernandez et al. 2008; del
Puerto et al. 2012).
Animals
Animals were housed in a room at controlled temperature and relative
humidity with alternating 12 h light and dark cycles and free access to
food and water “ad libitum”. Animal care protocols used in our labora-
tory are in conformity with the appropriate national legislation (53/
2013, BOE no. 1337), and guidelines of the Council of the European
Communities (2010/63/UE). All protocols were previously approved
by CSIC bioethics committee.
Induction of Transient Focal Cerebral Ischemia (tMCAO)
Fifteen adult male Wistar rats ∼8 weeks old (250–310 g) obtained from
CBM animal facilities were used for the study. Transient focal cerebral
ischemia was induced using the intraluminal suture method by the
middle cerebral artery occlusion (MCAO) procedure as described pre-
viously (Longa et al. 1989). Rats were anesthetized under isoﬂurane
(3% for induction and 1–1.5% for maintenance) delivered via a face
mask in oxygen-enriched air. The right common carotid artery (CCA)
was exposed and dissected; the right external carotid artery (ECA) and
the right internal carotid artery (ICA) were isolated. The ﬁrst artery
branches of the ECA and the pterygopalatine artery were electro-
cauterized using a High Temperature Cautery Power Handle (Aaron
Medical, Clearwater, USA). A 4-0 monoﬁlament nylon suture Daﬁlon
(B. Braun, Tuttlingen, Germany) with its tip rounded by heating and
poly-L-lysine coated, was introduced into the ECA lumen and advanced
into the ICA lumen until a mild resistance was felt, ∼2.2 cm beyond the
CCA bifurcation to occlude the origins of the middle cerebral artery
(MCA). The suture was secured in place with a ligature and was main-
tained for 90 min. After this time the suture was removed thus allowing
tissue reperfusion. The sham operated rats received all surgical pro-
cedures but without the suture insertion. All animals received ibupro-
fen (Dalsy, Abbot) as an analgesic, diluted at 200 mg/L in the drinking
water for 48 h after surgery. Some rats (sham and tMCAO) were treated
with 5 doses of BBG (50 mg/kg), by intraperitoneal injection at 3 and
6 h after reperfusion and then twice a day. All the animals were sacri-
ﬁced after 72 h of the onset of ischemia.
Neurologic Deﬁcit Score
The neurological deﬁcit score of each rat was measured before
surgery, during the ﬁrst 6 h after tMCAO induction and just before
administration of BGG, using a slightly modiﬁed version of the method
described by Yrjanheikki et al. (2005). The neurological deﬁcit score
of each rat was performed to check whether ischemia was correctly
induced and before each injection. A 6-point neuroscore test of the
motor status was recorded. Rats were scored 5 when both forelimbs
showed a normal extension towards the ﬂoor when lifted; 4 in the case
of dysfunctional rats with consistently reduced resistance to lateral
push towards the paretic side; 3 when rats did circle towards the
paretic side if pulled and lifted by the tail; 2 if circling towards
the paretic side when pulled by the tail; 1 when circling towards the
paretic side spontaneously and 0 if no spontaneous motion. Addition-
ally the animals were evaluated for any other neurological abnormal-
ities that had not been included in the previous grade scale, such as
keeping their balance, sensorial perception (acoustic, visual localiz-
ation), and reﬂexes (corneal, palpebral, postural correction). Only is-
chemic animals that showed a neurological score of 3 or lower during
the ﬁrst 6 h after ischemia induction were included in the study.
Tissue Collection
After 72 h of the onset of ischemia, the rats were sacriﬁced by deep an-
esthesia by intraperitoneal injection of a mixture of medetomidine
(375 μg/kg) and ketamine (112.5 mg/kg). Deeply anesthetized animals
were transcardially perfused with ice-cold phosphate-buffered saline
(PBS) and then with 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4). Brains were removed and postﬁxed 1 h at 4°C. Subsequently,
the brains were washed 3 times in PBS (15 min each), and cryopro-
tected in 30% sucrose in PBS at 4°C for 48–72 h. Finally, the brains
were embedded in Tissue-Tek medium (Sakura, Zoeterwoude, NL)
and stored at −20°C until used. Coronal cryostat sections (30-μm thick)
were obtained from each brain and sections located from +2 to −2 rela-
tive to the bregmawere selected for immunochemistry experiments.
Neuronal Culture
Mouse hippocampal neurons were prepared as previously described
(Kaech and Banker 2006). Neurons were obtained from E17 mouse
hippocampi, which were incubated in a 0.25% trypsin solution in
Ca2+/Mg2+ free Hank’s buffered salt solution (HBSS) and dissociated
using ﬁre polished Pasteur pipettes. The cells were plated on
polylysine-coated coverslips (1 mg/mL) at a density of 5000 cells/cm2
for 2 h in plating medium (minimum essential medium [MEM], 10%
horse serum, 0.6% glucose, Glutamax-I and antibiotics). Then, cover-
slips were inverted and transferred to culture dishes containing astro-
cytes. Astrocytes medium was replaced by neuronal culture medium
24 h before (Neurobasal medium, B27 supplement, Glutamax-I).
To avoid contact between neurons and astrocytes parafﬁn beads
were placed on coverslips before neuronal plating. 5 μM 1-β-D-
arabinofuranosylcytosine (AraC) was added after 2 days in culture to
avoid glial proliferation. Primary hippocampal neurons were nucleo-
fected using the Amaxa nucleofector kit for primary mammalian
neural cells (Amaxa Bioscience) according to the manufacturer’s
instructions. Nucleofection was performed using 3 μg total DNA and
3 × 106 cells for each nucleofection. Nucleofection efﬁciency was ∼15%
of neurons, based on the number of GFP positive neurons.
Immunoﬂuorescence
Coverslips were treated for 10 min with 50 mM NH4Cl and incubated in
blocking buffer (0.22% gelatin, 0.1% Triton X-100 in PBS) for 30 min,
before incubation with primary antibodies for 1 h at room temperature
in blocking buffer. Brain sections were incubated in blocking buffer
(10% goat serum, Triton X-100 0.5% in PBS) for 1 h before overnight
incubation with primary antibodies in the same buffer. The primary
antibodies used were: chicken anti-MAP2 (1:10 000, Abcam), mouse
anti-PanNaCh (1:75, Sigma), mouse antiankyrin G (1:100) from Neuro-
Mab. Rabbit anti βIV-spectrin (1:500), kindly provided by Dr Matthew
Rasband (Baylor College, Houston). The secondary antibodies used
were a donkey antimouse, antirabbit, or antichicken Alexa-Fluor-488,
594, or 647 (1:500). Nuclei were stained using 4′,6-diamidino-2-
phenylindole, and coverslips were mounted in Fluromount G. Images
were acquired on a vertical Axioskop-2plus microscope (Zeiss) or a
confocal microscope (LSM510, Zeiss) under the same conditions to
compare intensities. Figures were prepared for presentation using the
Adobe CS3 software. Quantiﬁcation of ﬂuorescence intensity at the AIS
was performed in 150 neurons per experimental condition in 3 inde-
pendent experiments. Measurements of AIS proteins location and in-
tensity in immunocytochemistry experiments were performed with
confocal images using MatLab script according to Grubb and Burrone
(2010). Brieﬂy, image stacks were converted into single maximum
intensity z-axis projections, exported as raw 16-bit TIFF ﬁles, and
imported into Matlab (Mathworks) for analysis using MatLab script.











We drew a line proﬁle starting at the soma that extended through the
axon, past the AIS. At each pixel along this proﬁle, ﬂuorescence inten-
sity values were averaged over a 3 × 3 pixel square centered on the
pixel of interest. Averaged proﬁles were then smoothed and normal-
ized between 1 (maximum smoothed ﬂuorescence, location of the AIS
max position) and 0 (minimum smoothed ﬂuorescence) and ﬁnally
were normalized to the mean control value in each experiment. AIS
start and end positions were obtained at the proximal and distal axonal
positions, respectively, where the normalized proﬁle declined to 0.33.
Hippocampal Slices Cultures and Biolistic Transfection
Slice cultures containing the hippocampus and entorhinal cortex were
obtained from postnatal day 7 mice as previously reported (Debanne
et al. 2008). Slices (350–450 µm) were cut in sucrose-based slicing sol-
ution (280 mM sucrose, 26 mM NaHCO3, 1.3 mM KCl, 1 mM CaCl2,
10 mM MgCl2, 11 mM D-glucose, 50 mM phenol red, and 2 mM kynure-
nate) and were maintained for 1 h at room temperature in oxygenated
(95% O2/5% CO2) standard artiﬁcial cerebrospinal ﬂuid (125 mM NaCl,
2.5 mM KCl, 0.8 mM NaH2PO4, 26 mM NaHCO3, 3 mM CaCl2, 2 mM
MgCl2, 50 mM phenol red, and 11 mM D-glucose). Each slice was
placed on 20-mm latex membranes (Millicell) inserted into 35-mm
Petri dishes containing 1 mL of culture medium (25 mL MEM, 12.5 mL
HBSS, 12.5 mL horse serum, 0.5 mL penicillin/streptomycin, 0.8 mL
glucose solution (1 M), 0.1 mL ascorbic acid solution (1 mg/mL),
0.4 mL 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
(1 M), 0.5 mL B27, and 8.95 mL water) and kept at 34°C, 95% O2–5%
CO2. To arrest glial proliferation, 5 µM Ara-C was added to the culture
medium. BBG treatment carried out at a concentration of 200 nM the
next day and kept for 2 days before electrophysiological experiments.
For transfection experiments, GFP or P2X7-GFP plasmids were deliv-
ered to brain slices using the Helyos gene-gun system (Bio-Rad) ac-
cording to the manufacturer’s instructions. Brieﬂy, gold particles
covered with each plasmid were delivered at a pressure of 100 dpi into
brain slices cultured for 2 days, and then brain slices were kept for a
further 48 h before electrophysiological recording or ﬁxation for im-
munohistochemistry. Slices were ﬁxed for immunohistochemistry
using 4% PFA for 1 h and washed in PBS. Slices were incubated over-
night with primary antibody: rabbit anti-βIV-spectrin; in PBS contain-
ing 20% goat serum and 0.5% Triton X-100. Secondary antibody was
incubated for 4 h before mounting brain slices in Fluoromount
G. Confocal images were acquired on a Leica TCS SP2 laser scanning
microscope (Leica Microsystems).
Electrophysiological Studies
Whole-cell patch clamp recordings were obtained from CA3 or L5 pyra-
midal neurons. The external solution contained (mM): 125 NaCl, 26
NaHCO3, 3 CaCl2, 2.5 KCl, 2 MgCl2, 0.8 NaH2PO4, and 10 D-glucose,
and was equilibrated with 95% O2–CO2. Patch pipettes (5–10 MΩ)
were ﬁlled with a solution containing (mM): 120 potassium gluconate,
20 KCl, 0.5 EGTA, 10 HEPES, 2 Na2ATP, 0.3 NaGTP and 2 MgCl2, pH
7.4. Recordings were made at 29°C. The voltage and current signals
were low-pass ﬁltered (3 kHz) and acquisition of sequences (500–
1.500 ms) was performed at a frequency of 0.1 Hz with P-clamp 8 or 10
(Axon Instruments). Sodium currents were evoked by a voltage step
(50 ms) from −70 to 0 mV. The capacitive and leak components of the
evoked current were subtracted with a conventional P/4 protocol. In-
trinsic neuronal excitability was monitored with depolarizing current
pulses (1 s) of increasing amplitude (from +10/+500 pA).
Statistical Analysis
Statistical analysis was carried out in Sigmaplot v11 (Systat Software
Inc.). Data for each independent sample were obtained from at least 3
independent experiments. Data from each experiment were collected
from at least 50 cells (between 50 and 80 cells) in each experimental
sample. We compared the data from each 2 experimental samples
using a t-test. Before carrying out the test, Sigmaplot software did
check for normal distribution of data. Some data sets failed the normal-
ity test (Shapiro–Wilk test). For that reason, we used a nonparametric
Mann–WhitneyU-test for all 2 independent sample comparisons (data in
Figs 1–5). All tests were 2-tailed. Differences were considered signiﬁcant
when P < 0.05. Electrophysiological data were compared using a t-test.
Results
P2X7 Activity Modulates AIS Structure and Protein
Composition
Calcium is an important regulator of AIS function and is also
involved in AIS disruption in brain ischemia. However, AIS dis-
ruption is not rescued after ischemia by an NMDA antagonist
(Schafer et al. 2009). As mentioned above, P2X7 receptor
allows calcium inﬂux to the same extent as NMDA receptors.
In order to analyze whether P2X7 receptors are involved in the
regulation of the AIS, we treated 20 DIV hippocampal neurons
with ATP, the P2X7 receptor agonist, increasing the concen-
tration of ATP in the extracellular medium (+1 mM) for 24 h.
ATP treatment signiﬁcantly reduced the concentration of
ankyrin G at the AIS (Fig. 1A,C), sparing only 62.3 ± 2.7% of
the ﬂuorescence observed in control neurons (100%). This
reduction was observed all along the AIS (Fig. 1D), without
any change in AIS length or position (Supplementary Fig. 1).
Similar results were obtained for voltage-gated sodium chan-
nels (PanNaCh), 70.6 ± 4.7% compared with control neurons
(Fig. 1B,E). Interestingly, cotreatment with ATP (+ 1 mM) and
BBG (100 nM) for 24 h not only prevented this reduction but
signiﬁcantly increased ankyrin G (111.4 ± 3.9%, Fig. 1A,C) and
PanNaCh (118.1% ± 7.1%) staining (Fig. 1B,E). BBG treatment
alone also increased the density of AIS proteins (Fig. 1A–D).
Hence, inhibition of P2X7 receptors prevents the loss of AIS
proteins produced by elevated extracellular ATP.
We then asked whether BBG-mediated P2X7 receptor inhi-
bition could rescue the loss of AIS proteins induced by ATP
treatment. Thus, neurons previously exposed to ATP (+1 mM)
for 21 h were treated with increasing concentrations of BBG
(10 , 50, and 100 nM) for 3 additional hours maintaining ATP
treatment (Fig. 2A). In these experimental conditions, con-
centrations of 50 nM BBG or higher rescued ankyrin G staining
at the AIS from 60.5 ± 2.5% in ATP treated neurons to
128.5 ± 5.4% (ATP + BBG 50 nM) or 98.1 ± 3.6% (ATP + BBG
100 nM) compared with 100% in control neurons (Fig. 2A–C).
Similar results were obtained for voltage-gated sodium chan-
nels (Fig. 2D,E). This result conﬁrms a role of the P2X7 recep-
tor in modulating density of AIS proteins.
In view of these results and to further substantiate the role
of P2X7, hippocampal neurons were nucleofected, before
plating, with plasmids expressing GFP or P2X7-GFP, and plas-
mids that coexpress P2X7 interference RNA (sh P2X7) or its
corresponding scrambled interference RNA (sc shRNA) and
GFP. Neurons were maintained 20 DIV and treated with BBG
(100 nM) or ATP (+1 mM) in different experimental conditions.
AISs of neurons expressing P2X7-GFP receptor displayed only
the 60.4 ± 4.1% and 67.3 ± 4.3% of the ﬂuorescence quantiﬁed
in GFP-nucleofected neurons for ankyrin G or sodium
channel, respectively (Fig. 3A,C,D). Ankyrin G and sodium
channel ﬂuorescence in GFP-nucleofected neurons was equal
to that observed in surrounding nonnucleofected neurons.
This reduction of AIS proteins produced by P2X7-GFP
expression was prevented, and expression was even increased,
by combined treatment with BBG for the last 24 h (116 ± 6.8%,
PanNaCh and 124.7 ± 9.4%, ankyrin G), as previously shown











for BBG in experiments where neurons were treated with the
P2X7 agonist ATP (Fig. 1A,C,D). Next, we nucleofected
neurons with P2X7 interference RNA or scrambled interfer-
ence RNA to analyze the effect of ATP on AIS proteins in
neurons with reduced P2X7 function. The expression of P2X7
interference RNA signiﬁcantly increased the expression of
ankyrin G (135.7 ± 11.5%), indicating a role for P2X7 in the
downregulation of AIS protein tethering at the AIS. This fact
was conﬁrmed when neurons expressing P2X7 interference
RNA were treated with ATP. While neurons that were non-
nucleofected or nucleofected with scrambled interference RNA
showed a decreased AIS protein staining (75.9% ± 4.7%), those
with reduced P2X7 expression were not affected by ATP treat-
ment, and ankyrin G and sodium channels staining at the AIS
was similar to control neurons in the absence of ATP treatment,
113.9 ± 10.4% and 116.2 ± 9.8%, respectively. (Fig. 3B,E,F).
These data demonstrate a role for P2X7 and extracellular
ATP in the regulation of AIS proteins, which then raises the
question as to the molecular mechanisms modulated by P2X7
that regulate the tethering and maintenance of proteins at
the AIS?
P2X7 Modulation of AIS Proteins is Mediated by Calcium
and Calpain
Activation of P2X7 by ATP triggers calcium inﬂux and in-
creased intracellular calcium concentration. Calcium entry is
mediated directly by P2X7 purinoreceptor, but also by indirect
opening of voltage-dependent calcium channels to further in-
crease [Ca2+]i. Studies in NG108-15 cells demonstrate that at
least 31% of ATP-mediated calcium inﬂux is not prevented by a
combination of voltage-dependent calcium channels blockers
(Brater et al. 1999), which in contrast prevents completely the
KCl mediated intracellular calcium increase. Thus, we ﬁrst
checked the effect of increased extracellular calcium concen-
tration on the AIS. The extracellular calcium concentration was
Figure 1. P2X7 receptor activation reduced the density of ankyrin G and voltage-gated sodium channels at the AIS (A,B) Hippocampal neurons were cultured for 20 DIV and then
treated for 24 h with 1 mM ATP, 100 nM BBG or the combination of both. Neurons were ﬁxed and stained with anti-MAP2 antibody (blue) and antiankyrin G (A) or PanNaCh (B)
antibodies (green). The ×4 magniﬁcations of AIS staining are shown under each image. Scale bar = 50 μm. Images of each experimental condition from 3 independent
experiments obtained under the same conditions. Ankyrin G and PanNaCh ﬂuorescence intensity were measured using Matlab software. (C) Quantiﬁcation of total integrated ankyrin
G ﬂuorescence intensity. (D) Quantiﬁcation of ankyrin G ﬂuorescence intensity along the AIS. (E) Quantiﬁcation of total integrated PanNaCh ﬂuorescence intensity. All quantiﬁcations
were done in at least 50 neurons in each experimental condition and experiment. Data are represented as the mean ± SEM of at least 3 independent experiments. Individual data
were normalized to the control mean. (*P<0.05; ***P< 0.001, Mann–Whitney test).











increased by adding 2 mM or 5 mM CaCl2 to the culture
medium of 20 DIV hippocampal neurons for 24 h. Both treat-
ments reduced the density of ankyrin G at the AIS (62.7 ± 3.2%,
2 mM and 27.4 ± 2.6%, 5 mM). In the same experiments, co-
treatment with 100 nM BBG impaired the reduction observed
with 2 mM CaCl2 (117.7% ± 6%), indicating that the effect of
calcium was mediated by the P2X7 receptor (Fig. 4A,B). Then,
we analyzed whether decreasing the extracellular calcium con-
centration with EGTA prevented the ATP-mediated reduction
of ankyrin G. In fact, treatment of neurons for 24 h with ATP in
the presence of 2 mM EGTA preserved ankyrin G levels
(89.8 ± 6.2% vs. 58.2 ± 2.8% in ATP treated neurons) (Fig. 4B).
Similar results were obtained for voltage-gated sodium chan-
nels (Fig. 4C,F), for which expression at the AIS was reduced
by increased extracellular calcium concentration and ATP, and
stabilized by EGTA or BBG. These data were conﬁrmed in
neurons expressing P2X7-GFP or P2X7 interference RNA. The
addition of 2 mM CaCl2 to the medium failed to decrease
ankyrin G levels in neurons when P2X7 receptor expression
was reduced by interference RNA (100.1 ± 10.9% vs.
50.1 ± 3.4% in scrambled shRNA nucleofected neurons;
Fig. 4D), demonstrating that calcium mediated reduction of
AIS proteins depends on P2X7. In a similar way, sequestering
extracellular calcium with 2 mM EGTA blocked the reduction
in the concentration of AIS proteins mediated by P2X7-GFP
(109.7 ± 6.8% vs. 63.6 ± 3.7% for ankyrin G and 99.4 ± 7.7% vs.
67.8 ± 4.3% for PanNaCh; Fig. 4D,E,G). Once a role for calcium
and P2X7 in AIS regulation was conﬁrmed and taking into
account that the inhibition of calpain, a calcium-activated pro-
tease, prevents AIS injury (Schafer et al. 2009), we analyzed
whether 2 calpain inhibitors (calpeptin and MDL) could
prevent the decrease in AIS proteins mediated by ATP and P2X7
(Fig. 5). Hippocampal neurons at 20 DIV were treated with 1
mM ATP in the presence or absence of 10 μM calpeptin or
50 nM MDL for 24 h. The ATP-induced reduction of ankyrin G
and sodium channel staining was prevented by both calpain
inhibitors (Fig. 5A–C). Similar results were obtained in neurons
expressing P2X7-GFP (Fig. 5D–F), where calpeptin and MDL
blocked the reduction in ankyrin G and sodium channel
density, maintaining levels similar to those of nonnucleofected
neurons (Fig. 5D).
P2X7 Receptors Modulate Voltage-gated Sodium Currents
and Neuronal Excitability
All these data suggest that changes in P2X7 receptor activity
are important for the regulation of voltage-gated ion channels
at the AIS, implicating this receptor in the modulation of
neuronal excitability. To corroborate the data obtained in hip-
pocampal cultured neurons and consolidate this latter hypoth-
esis, hippocampal slice cultures containing the entorhinal
cortex were used. Slices were treated with the P2X7 antagonist,
BBG and kept in culture for at least 48 h before testing the elec-
trophysiological properties of the neurons (Fig. 6). CA3 pyra-
midal neurons treated with BBG (200 nM) for 48 h, displayed
an enhanced sodium current (148.5 ± 13.8%) compared with
control neurons (100 ± 9.9%, Fig. 6A). Then, we analyzed in
current clamp whether neuronal excitability and action poten-
tial number was altered by the P2X7 antagonist. Consistent
with voltage clamp recordings, BBG increased the number of
action potentials (Fig. 6B).
To consolidate the role of P2X7 receptors in regulating
sodium current and neuronal excitability, we expressed
P2X7-GFP receptors in brain slices using the GeneGun
Figure 2. The P2X7 receptor antagonist BBG rescued ankyrin G and sodium channel density at the AIS after ATP treatment. Hippocampal neurons were cultured for 20 DIV before
treatment with ATP for 24 h. BBG was added for the last 3 h of treatment at increasing concentrations from 10 to 100 nM. Neurons were ﬁxed and stained with antibodies against
ankyrin G (green) or sodium channels (PanNaCh, green) and MAP2 (blue). (A) Quantiﬁcation of total integrated ankyrin G ﬂuorescence intensity. Data are represented as the
mean ± SEM of 3 independent experiments (B) Mean ± SEM ankyrin G ﬂuorescence intensity along the AIS of 3 experiments. (C) Representative images and ×4 magniﬁcations of
control and treated neurons stained with antiankyrin G antibody (green) and MAP2 (blue). Axons initial segments in each ﬁgure are identiﬁed by letters and the corresponding
magniﬁcation is shown at the bottom of each image. Scale bar = 50 μm. (D) Quantiﬁcation of integrated sodium channel ﬂuorescence intensity at the AIS. Data are represented as
the mean ± SEM of 3 independent experiments. (E) Representative images and ×4 magniﬁcations of control and treated neurons stained with antiPanNaCh antibody (green) and
MAP2 (blue). All quantiﬁcations were done in at least 50 neurons in each experimental and experiment. Individual data were normalized to the control mean. (***P< 0.001,
Mann–Whitney test).











technique, and due to the low number of hippocampal
neurons transfected, we decided to analyze layer 5 pyramidal
cortical neurons (Fig. 7). Electrophysiological recordings were
made in neurons expressing P2X7-GFP and nearby control
neurons to minimize possible variability due to culture con-
ditions or to shot gold particles. Previous studies have shown
that GFP expression do not affect neither resting membrane
potential, membrane conductance, actions potentials, nor
ﬁring accommodation (Ehrengruber et al. 2001). To conﬁrm
that P2X7-GFP expression was affecting AIS in brain slices,
some slices were ﬁxed and stained with an AIS marker
(βIV-spectrin antibody). In P2X7-GFP positive neurons,
βIV-spectrin staining was absent or much reduced at the AIS,
compared with surrounding nontransfected neurons, or
neurons transfected with GFP or P2X7 interference RNA
(Fig. 7A,B). Conﬁrming the reduction of sodium channel
density at the AIS of cultured neurons treated with ATP, layer 5
cortical neurons expressing P2X7-GFP had a diminished
sodium current amplitude (383.2 ± 67.5 pA/pF) vs. nearby
control neurons (697.6 ± 117.8 pA/pF) (Fig. 7C). In addition,
P2X7-GFP positive neurons showed a signiﬁcant reduction in
the number of action potentials and a higher current threshold
for the generation of action potentials (Fig. 7D,E).
P2X7 Antagonism Prevents Injury of the AIS After Brain
Ischemia
Our results demonstrate a role of P2X7 receptor and calcium in
AIS modulation. Next, we checked whether the calcium-
permeable ATP-gated P2X7 receptor could impair AIS disruption
or play a role in AIS modulation in brain ischemia. Transient
ischemia was induced by MCAO in 6 rats for 90 min before
Figure 3. Effects of expression of P2X7 receptor-GFP or P2X7 receptor interference RNA on AIS protein density. Hippocampal neurons were nucleofected with plasmids expressing
GFP or P2X7-GFP (A) and scrambled interference RNA or P2X7 interference RNA (B) and maintained in culture for 20 DIV before treatment with BBG or ATP for 24 h. Neurons were
ﬁxed and stained with antibodies against ankyrin G or PanNaCh (red). Nucleofected neurons were identiﬁed by GFP expression (green). The ×4 magniﬁcations of AISs from
nucleofected neurons are shown under each image. Scale bar = 50 μm. (C,E) Quantiﬁcation of integrated ankyrin G ﬂuorescence intensity at the AIS. (D,F) Quantiﬁcation of
integrated PanNaCh ﬂuorescence intensity. All quantiﬁcations were done in at least 50 neurons in each experimental and experiment. Data are represented as the mean ± SEM of
at least 3 independent experiments. Individual data were normalized to the control mean. (n.s.: nonsigniﬁcant; *P<0.05; **P< 0.01; ***P< 0.001, Mann–Whitney test).











allowing reperfusion. In 2 independent set of experiments, rats
were separated in 2 groups that were treated intraperitoneally
with BBG or vehicle after 3 and 6 h following reperfusion, and
then twice a day. A third group was sham-operated without
ischemia induction. Motor neuroscore tests gave a score of 5 in
sham-operated rats, while rats subjected to ischemia kept the
initial score of 3 until 72 h. However, BBG treated rats recov-
ered partially obtaining a score of 4 at 72 h (P < 0.05, t-test).
Our results show a signiﬁcant reduction in the number of AIS
identiﬁed by ankyrin G and βIV-spectrin staining in ischemic
brain tissue (Fig. 8A,C) compared with contralateral nonis-
chemic cortical region (36.3 ± 7.8%, ipsilateral vs. 100%,
contralateral; P < 0.001, n = 5). However, when rats were treated
with BBG (50 mg/kg), the number of AIS preserved and ident-
iﬁable in the ischemia region by ankyrin G and βIV-spectrin
staining was signiﬁcantly increased (88.6 ± 5.9% vs. 36.3.7 ±
7.8% in vehicle treated rats; P < 0.001, n = 5) (Fig. 8B,D). P2X7
staining was not detected at the AIS, suggesting that P2X7 recep-
tors in other neuronal structures regulate AIS structure.
In conclusion, our data demonstrate the involvement of
P2X7 receptor activity in the regulation of voltage-gated
sodium channels and structural protein density at the AIS, and
suggest a major role of the purinergic system in physiological
and pathological modulation of neuronal excitability.
Figure 4. P2X7 receptor-dependent calcium inﬂux mediates the reduction in AIS protein density. (A) Hippocampal neurons were cultured for 20 days and then calcium
concentration was increased by adding CaCl2 (+2 mM) for 24 h in the presence or absence of 100 nM BBG. Neurons were ﬁxed, stained with antiankyrin G antibody (green) and
MAP2 (blue). Scale bar = 50 μm. (B) Quantiﬁcation of integrated ankyrin G ﬂuorescence intensity in neurons cultured in the presence of CaCl2 (+2 or +5 mM), ATP (+1 mM),
100 nM BBG or EGTA (1–2 mM) and their corresponding combined treatments. (C) Sodium channel expression at the AIS of hippocampal neurons treated with 1 mM ATP and 2
mM EGTA. Neurons were stained with anti-PanNaCh antibody (green) and MAP2 (blue). Scale bar = 20 μm. (D) Quantiﬁcation of integrated ankyrin G ﬂuorescence intensity in
neurons nucleofected with GFP, P2X7-GFP, scrambled shRNA, or P2X7 shRNA and treated with 2 mM EGTA or 2 mM CaCl2. (E) Hippocampal neurons nucleofected with P2X7-GFP,
cultured for 20 DIV and treated with 2 mM EGTA for 24 h. Neurons were ﬁxed and stained with anti-PanNaCh antibody. The ×4 magniﬁcation of non-nucleofected and P2X7-GFP
nucleofected neurons identiﬁed by letters are shown in the corresponding bottom panels. Scale bar = 50 μm. (F) Quantiﬁcation of integrated sodium channel ﬂuorescence intensity
in neurons treated with 1 mM ATP or 2 mM CaCl2 alone or in combination with 2 mM EGTA or 100 nM BBG, respectively. (G) Quantiﬁcation of integrated sodium channel
ﬂuorescence intensity in control or 2 mM EGTA treated neurons nucleofected with GFP or P2X7-GFP. (**P<0.01; ***P< 0.001, Mann–Whitney test).












Ion channel modiﬁcations and mutations in the AIS have been
related to a variety of brain diseases (for a review see, (Bufﬁng-
ton and Rasband 2011). Our study demonstrates a new role for
P2X7 receptors in the regulation and maintenance of the struc-
tural and functional properties of the AIS. P2X7 inhibition not
only prevents AIS disruption after MCAO-induced brain ische-
mia, but also enhances neuronal excitability in cultured brain
slices. In fact, ATP-mediated P2X7 activation or its exogenous
receptor expression diminishes βIV-spectrin, ankyrin G and
voltage-gated sodium channel expression at the AIS in brain
slices or cultured hippocampal neurons. This occurs through
calcium/calpain-mediateddegradation,reducingsodiumcurrent
amplitude and the number of action potentials. We show that
P2X7 receptor is not detectable in the AIS, suggesting that
mechanisms outside the AIS may regulate protein expression
at the AIS. Furthermore, these results indicate a new major role
of the purinergic system in the functional regulation of the AIS
in physiological and pathological conditions.
P2X7 Modulation of AIS Function
Brain injury and neurodegenerative disorders are generally
due to perturbations in the regulation of glial cells and/or
neurons. P2X7 receptors are widely expressed in non-neuronal
cells and neurons, and we cannot exclude the participation of
non-neuronal P2X7 receptors in more complex models where
glial cells are in closed contact with neurons. However, our
data using a model of pure cultured neurons, where support-
ing glial cells are not in contact, point to a role of neuronal
P2X7 receptor activation by ATP in the loss of AIS proteins. In
fact, oxygen/glucose deprivation in cultured cortical or hippo-
campal neurons, in the absence of glial cells, results in the loss
of AIS protein staining (Schafer et al. 2009) and this happens
within the ﬁrst 2 h before cell death. In our study, stimulation
Figure 5. Calpain inhibition impairs the reduction of AIS protein density mediated by P2X7 receptors. (A) 20 DIV hippocampal neurons treated for the last 24 h with 1 mM ATP
alone or in combination with the calpain inhibitor MDL-28170 (50 nM). Neurons were ﬁxed and stained with anti-PanNaCh (green) and anti-MAP2 (blue) antibodies. Bottom panels
show a ×4 magniﬁcation of AISs. (B,C) Quantiﬁcation of integrated ankyrin G and sodium channels ﬂuorescence intensity in neurons treated with 1 mM ATP alone or in combination
with 10 μM calpeptin or 50 nM MDL. (D) 20 DIV hippocampal neurons nucleofected with P2X7-GFP plasmid and treated with the calpain inhibitors MDL (50 nM) or calpeptin (10
μM). Neurons were stained with antiankyrin G antibody (red). The ×4 magniﬁcations show AISs from control nonnucleofected and P2X7-GFP nucleofected neurons. (E,F)
Quantiﬁcation of integrated ankyrin G and sodium channel ﬂuorescence intensity in neurons nucleofected with GFP or P2X7-GFP plasmids and treated for 24 h with calpain inhibitors,
MDL, or calpeptin. (**P<0.01; ***P<0.001, Mann–Whitney test).











of P2X7 receptor by ATP diminished the concentration of pro-
teins at the AIS. In contrast, the AIS was still faintly detectable,
suggesting that P2X7 receptor exerts a regulatory mechanism
that controls the density of AIS proteins without completely
disrupting AIS structure. In fact, P2X7 suppression impaired
this reduction and even increased sodium channel density, as
observed when P2X7 receptor was inhibited by BBG. More-
over, after prolonged ATP treatment, P2X7 inhibition rescued
the density of AIS proteins, suggesting that there is a physio-
logical turnover of AIS proteins. Thus, ﬁnal concentration of
some proteins at the AIS may depend on the equilibrium
between calpain degradation and membrane insertion at the
AIS of proteins from a reserve pool. This hypothesis may
explain why P2X7 inhibition with BBG increases AIS proteins
density. Further experiments will be necessary to understand
how AIS proteins density is regulated and their contribution to
neuronal function. Hence, the P2X7 receptor has a physiologi-
cal role in AIS regulation, besides its pathological role in ische-
mia that is probably coupled to other inﬂammatory mechanisms
(Friedle et al. 2010). These changes in sodium channel ex-
pression were conﬁrmed by our electrophysiological studies in
neurons from organotypic slice cultures, containing the hippo-
campus and the cortex, where P2X7 exogenous expression in
neurons reduced sodium current amplitude by 50% and dimin-
ished the expression of the scaffolding protein βIV-spectrin in
the AIS. As mentioned above, P2X7 activity can trigger ATP
release to the extracellular medium (Gutierrez-Martin et al.
2011), thus accounting for the reduction of AIS proteins
density by exogeneous expression of P2X7-GFP. In contrast,
BBG inhibition increased sodium current amplitude in the
same range. Moreover, in both cases these changes in sodium
current were reﬂected by the number of action potentials gen-
erated, corroborating the data obtained from cultured neurons.
A recent report has pointed out that micromolar concentrations
of BBG may inactivate Nav1.3 sodium channels in neuroblasto-
ma cells (Jo and Bean 2011). We do not believe that this mech-
anism contributes to our data since BBG was used at lower
concentrations (50–200 nM;, i.e., the range for speciﬁc inhi-
bition of the P2X7 receptor (Jiang et al. 2000)). In addition,
BBG actually increased sodium channel density, neuronal excit-
ability and sodium currents. Furthermore, the concentration of
BBG measured in mouse brain after repetitive intraperitoneal
injections of BBG never exceeds 200 nM (Diaz-Hernandez et al.
2012).
What is the mechanism of P2X7-dependent regulation of
AIS structure? Sustained activation of calpain has been
described in neurodegenerative diseases, such as Parkinson’s,
Alzheimer’s or Huntington’s disease (for a review see, Vosler
et al. 2008), and traumatic brain or spinal cord injury (Kampﬂ
et al. 1996; Ray et al. 2003). Calcium (and subsequently
calpain) disrupts the AIS cytoskeleton. This process is thought
to account for the AIS dissipation observed in brain ischemia
since it is prevented by the calpain inhibitor MDL-28170
(Schafer et al. 2009). Calpain is activated by increased intra-
cellular calcium concentration. Our data show that the P2X7
receptor mediates the calcium inﬂux at the origin of these al-
terations in the AIS. We cannot exclude that voltage-gated
calcium channels have a minor contribution as they may be
opened as a consequence of P2X7 activation. In fact, Brater
et al. (1999) described in NG108-15 cells that 28% of
ATP-induced calcium inﬂux is blocked by the L-type calcium
channels blocker, nifedipine. Recent evidences show that
calcium inﬂux through L-type voltage-gated calcium channels
is involved in the modulation of another type of AIS plasticity,
modulating AIS position or length (Grubb and Burrone 2010;
Kuba et al. 2010). However, authors did not report any change
in AIS proteins density, and our study shows that P2X7
mediated mechanisms do not change AIS position or length
(Supplementary Fig. 1). Thus, our data suggest that ATP-
mediated activation of P2X7 receptors control a different type
of AIS plasticity in response to different stimulus. Even more,
calcium mediated modulation of AIS position do not depend
on calpain, but instead needs calcineurin activation (Evans
et al. 2013). In fact, we show that calcium-dependent altera-
tions in the AIS were abolished by calpain inhibitors, P2X7
receptor inhibition or P2X7 knockdown. Reciprocally, extra-
cellular calcium depletion impaired the reduction in AIS
protein density induced by ATP or P2X7-GFP expression. More-
over, it has been reported that P2X7 activation by ATP induces
calpain-dependent protein cleavage in cortical neurons and Par
C5 cells (Hwang et al. 2009; Nishida et al. 2012). Furthermore,
recent studies have shown that βIV-spectrin, ankyrin G, and
voltage-gated sodium channels are substrates for calpain
(Schafer et al. 2009; von Reyn et al. 2009). This may account for
the reduction of βIV-spectrin, ankyrin G ,and sodium channels
at the AIS observed in our study, and its recovery by calpain
inhibitors, P2X7 antagonist or P2X7 interference RNA.
P2X7 Involvement in AIS Disruption During Brain
Ischemia
Due to the role of AIS in neuronal excitability, physiological and
pathological modiﬁcations in its organization are expected to
generate neurological disorders. Multiple nonsynonymous single
nucleotide polymorphisms (NS-SNPs) have been identiﬁed in the
Figure 6. Inhibition of P2X7 receptors by BBG increases sodium current amplitude
and intrinsic neuronal excitability. (A) Plot of the sodium current in CA3 hippocampal
neurons from control or 200 nM BBG treated slices (350 μm). Sodium currents
measured in CA3 hippocampal neurons were evoked by a depolarizing step from −70
to 0 mV. (B) Mean ± SEM normalized sodium current amplitude in 200 nM BBG
treated neurons compared with control neurons. (*P< 0.02; paired t-test). Note the
signiﬁcant increase in the sodium current amplitude in BBG treated neurons. (C)
Representative ﬁring proﬁles of CA3 hippocampal neurons from control and 200 nM
BBG treated slices. (D) Input–output curves for control (○) and BBG (•) treatedneurons. Note the signiﬁcant increase in excitability for BBG treated neurons (t-test,
*P<0.02).











human P2X7 gene, which generate different mutant P2X7
receptors. Most of these mutations engender modiﬁcations in
calcium permeability and are associated with diseases, including
bipolar disorder, major depressive disorder, anxiety disorders,
multiple sclerosis, ischemic stroke, and neuropathic pain (Jiang
et al. 2013). Our results demonstrate a role of the P2X7 puriner-
gic receptor in the damage suffered by the AIS after ischemia/
reperfusion, and protection by the P2X7 antagonist, BBG, when
applied in the ﬁrst 3 h after ischemia induction. In this sense, it
is noteworthy that 17β-oestradiol, a natural protector against is-
chemic injury (Perez-Alvarez et al. 2012) inhibits P2X7 receptor
activity (Cario-Toumaniantz et al. 1998). Interestingly, BBG
treatment after ischemia exerts a neuroprotective effect and
moderately reduces both neuronal death (Arbeloa et al. 2012),
and brain edema after traumatic brain injury (Kimbler et al.
2012). A previous study has shown that the AIS is disrupted
before cell death when brain ischemia is induced by MCAO
(Schafer et al. 2009), leading to a loss of structural and func-
tional proteins (βIV-spectrin, ankyrin G and voltage-gated ion
channels). In contrast to our study, this was not prevented by
the inhibition of calcium-permeable NMDA receptors using
MK-801, which in turn can increase neuronal survival after
oxygen/glucose deprivation (Schafer et al. 2009). While it has
been shown that P2X7 receptor levels measured by immunoblot
do not change after traumatic brain injury (Kimbler et al. 2012),
this receptor exhibits an increased response to ATP after is-
chemic insult (Wirkner et al. 2005), even in the absence of an
increment in P2X7 expression. However, other studies demon-
strate up-regulation of P2X7 mRNA in neurons after focal cer-
ebral ischemia (Cavaliere et al. 2004; Franke et al. 2004). In
agreement with these studies our experiments indicated that the
increased P2X7 receptor density induced by exogenous
expression in brain slices is sufﬁcient to disrupt AIS integrity.
Moreover, the extracellular concentration of the P2X7 receptor
agonist ATP is highly augmented after MCAO (Melani et al.
2005) or spinal cord injury (Wang et al. 2004). Reciprocally, ATP
injection increases brain damage after ischemia (Zhang et al.
2013), while ATP depletion by ectonucleotidases may play a
role in protection against brain damage after ischemia (Melani
et al. 2012). Hence, an increase in either extracellular ATP or
P2X7 receptor expression mediates the harmful processes acti-
vated during brain ischemia. In view of these results, P2X7 re-
ceptors seem to be a major source of calcium inﬂux involved in
AIS disruption after brain ischemia, and also a good candidate
to modulate AIS function in certain physiological conditions.
In conclusion, our results support a role for the P2X7 puri-
nergic receptor in the modulation of protein density at the AIS
and neuronal excitability. As different levels of ATP and other
Figure 7. Expression of P2X7-GFP receptors in cortical neurons diminishes sodium current amplitude, intrinsic excitability, and βIV-spectrin density at the AIS. (A,B) GFP (A) or
P2X7-GFP (B) expression plasmids were transfected in 450 μm brain slices including hippocampus and entorhinal cortex using the biolistic technique GeneGun. Brain slices were
ﬁxed and stained using an antibody against the AIS marker βIV-spectrin (red). Images show layer V cortical neurons. Note that the AIS of neurons expressing GFP show clear
βIV-spectrin staining similar to that of surrounding GFP negative neurons, while βIV-spectrin staining is absent from the AIS of P2X7-GFP positive neurons. (C) Plot of the sodium
current in L5 cortical neurons from control (GFP) or P2X7-GFP positive neurons. Sodium currents were evoked by a depolarizing step from −70 to 0 mV. The graph represents the
mean ± SEM of the sodium current amplitude measured in control or P2X7-GFP neurons (n=8; *P< 0.05; t-test). Note the signiﬁcant reduction in the sodium current amplitude
in P2X7-GFP positive neurons. (D) Representative ﬁring proﬁles of L5 cortical neurons from control and P2X7-GFP neurons. (E) Input–output curves for control (○) and P2X7-GFP
positive neurons (•). Note the signiﬁcant neuronal excitability decrease in P2X7-GFP neurons (t-test, *P< 0.01).











related purines are released into the extracellular medium in
different physiological as well as pathological conditions, it is
tempting to propose that other purinergic receptors, such as
P2Y receptors, and purines can also contribute to AIS modu-
lation. In fact, a selective agonist of the P2Y1 receptor,
2-MeSADP, have been identiﬁed as a neuroprotective agent in
a photothrombosis model of brain ischemia (Zheng et al.
2010). Finally, further experiments are necessary to under-
stand how the activity of P2X7 receptors and calpain are ﬁnely
regulated during structural modulation of the AIS, as well as
the possible participation of non-neuronal cells in the regu-
lation of AIS function by the purinergic system.
Supplementary Material
Supplementary material can be found at: http://www.cercor.
oxfordjournals.org/.
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Figure 8. A P2X7 receptor antagonist prevents AIS injury in ischemia. (A,B) Rats were operated to induce brain ischemia by middle cerebral artery occlusion (MCAO). Rats were
injected intraperitoneally with PBS or the P2X7 receptor antagonist BBG (50 mg/kg) as described in Materials and Methods section. Brains were collected 72 h later. Coronal
sections (30 μm) were stained with antiankyrin G (red) and antiβIV-spectrin (green) antibodies. Nuclei were stained using 4′,6-diamidino-2-phenylindole (blue). Images show
representative pictures from the parietal cortex region of the contralateral side (undamaged region) or ipsilateral side (ischemic zone) from rat brains treated with vehicle (PBS) or
BBG. White square zones were magniﬁed 3 times and shown in the corresponding bottom panels. (C,D) Images from regions of ischemia damage from rat brains of a second
independent experiment showing the absence of ankyrin G staining (green) in vehicle treated rats (C) and its protection in BBG treated rats (D). Scale bar = 50 μm.
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